Proto Labs, Inc. PRLB
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 35.02M | 30.48M | 25.75M | 21.24M | 14.84M |
| Total Depreciation and Amortization | 30.02M | 33.04M | 33.52M | 34.14M | 34.85M |
| Total Amortization of Deferred Charges | 2.70M | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.00M | 26.13M | 21.15M | 18.55M | 21.77M |
| Change in Net Operating Assets | -16.54M | -11.13M | -6.76M | 567.00K | 3.89M |
| Cash from Operations | 72.20M | 78.52M | 73.66M | 74.50M | 75.35M |
| Capital Expenditure | -23.59M | -21.86M | -17.12M | -14.84M | -7.62M |
| Sale of Property, Plant, and Equipment | 1.30M | 2.11M | 2.11M | 834.00K | 811.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.61M | -2.09M | -262.00K | 598.00K | -3.89M |
| Cash from Investing | -29.90M | -21.83M | -15.27M | -13.41M | -10.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -265.00K | -316.00K | -312.00K | -309.00K | -307.00K |
| Issuance of Common Stock | 10.16M | 11.52M | 9.66M | 6.34M | 6.12M |
| Repurchase of Common Stock | -22.67M | -30.29M | -27.13M | -46.40M | -54.25M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.78M | -19.08M | -17.78M | -40.37M | -48.43M |
| Foreign Exchange rate Adjustments | -165.00K | -75.00K | 670.00K | 1.03M | 336.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.36M | 37.54M | 41.28M | 21.76M | 16.55M |